• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然植物多糖对肠道微生物群介导的代谢紊乱的影响及其机制

The Influence and Mechanisms of Natural Plant Polysaccharides on Intestinal Microbiota-Mediated Metabolic Disorders.

作者信息

Chen Yong, Li Hui, Lai Furao, Min Tian, Wu Hui, Zhan Qiping

机构信息

College of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.

College of Chemical and Biological Engineering, Guangxi Minzu Normal University, Chongzuo 532200, China.

出版信息

Foods. 2024 Nov 30;13(23):3882. doi: 10.3390/foods13233882.

DOI:10.3390/foods13233882
PMID:39682954
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11640612/
Abstract

Natural plant polysaccharides are renowned for their broad spectrum of biological activities, making them invaluable in both the pharmaceutical and food industries. Their safety, characterized by low toxicity and minimal side effects, coupled with their potential therapeutic properties, positions them as crucial elements in health-related applications. The functional effectiveness of these polysaccharides is deeply connected to their structural attributes, including molecular weight, monosaccharide components, and types of glycosidic bonds. These structural elements influence how polysaccharides interact with the gut microbiota, potentially alleviating various metabolic and inflammatory disorders such as inflammatory bowel disease, diabetes, liver-associated pathologies, obesity, and kidney diseases. The polysaccharides operate through a range of biological mechanisms. They enhance the formation of short-chain fatty acids, which are pivotal in keeping intestinal health and metabolic balance. Additionally, they strengthen the intestinal mucosal barrier, crucial for deterring the ingress of pathogens and toxins into the host system. By modulating the immune responses within the gut, they help in managing immune-mediated disorders, and their role in activating specific cellular signaling pathways further underscores their therapeutic potential. The review delves into the intricate structure-activity relationships of various natural polysaccharides and their interactions with the intestinal flora. By understanding these relationships, the scientific community can develop targeted strategies for the use of polysaccharides in therapeutics, potentially leading to innovative treatments for a range of diseases. Furthermore, the insights gained can drive the advancement of research in natural polysaccharide applications, providing direction for novel dietary supplements and functional foods designed to support gut health and overall well-being.

摘要

天然植物多糖以其广泛的生物活性而闻名,这使其在制药和食品工业中都具有极高的价值。它们具有低毒性和最小副作用的安全性特点,再加上其潜在的治疗特性,使其成为健康相关应用中的关键要素。这些多糖的功能有效性与其结构属性密切相关,包括分子量、单糖成分和糖苷键类型。这些结构元素影响多糖与肠道微生物群的相互作用方式,可能缓解各种代谢和炎症性疾病,如炎症性肠病、糖尿病、肝脏相关疾病、肥胖症和肾脏疾病。多糖通过一系列生物学机制发挥作用。它们促进短链脂肪酸的形成,而短链脂肪酸对于维持肠道健康和代谢平衡至关重要。此外,它们强化肠道黏膜屏障,这对于阻止病原体和毒素进入宿主系统至关重要。通过调节肠道内的免疫反应,它们有助于控制免疫介导的疾病,并且它们在激活特定细胞信号通路中的作用进一步凸显了其治疗潜力。这篇综述深入探讨了各种天然多糖复杂的结构 - 活性关系及其与肠道菌群的相互作用。通过了解这些关系,科学界可以制定针对性的策略,将多糖用于治疗,这可能为一系列疾病带来创新疗法。此外,所获得的见解可以推动天然多糖应用研究的进展,为旨在支持肠道健康和整体福祉的新型膳食补充剂和功能性食品提供方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f6/11640612/f7c2182ac0e5/foods-13-03882-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f6/11640612/e8eddeaee2f6/foods-13-03882-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f6/11640612/de473b1a71f8/foods-13-03882-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f6/11640612/ba845c82539e/foods-13-03882-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f6/11640612/a58cfc0e7bd0/foods-13-03882-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f6/11640612/f7c2182ac0e5/foods-13-03882-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f6/11640612/e8eddeaee2f6/foods-13-03882-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f6/11640612/de473b1a71f8/foods-13-03882-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f6/11640612/ba845c82539e/foods-13-03882-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f6/11640612/a58cfc0e7bd0/foods-13-03882-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f6/11640612/f7c2182ac0e5/foods-13-03882-g005.jpg

相似文献

1
The Influence and Mechanisms of Natural Plant Polysaccharides on Intestinal Microbiota-Mediated Metabolic Disorders.天然植物多糖对肠道微生物群介导的代谢紊乱的影响及其机制
Foods. 2024 Nov 30;13(23):3882. doi: 10.3390/foods13233882.
2
The Interaction between Mushroom Polysaccharides and Gut Microbiota and Their Effect on Human Health: A Review.蘑菇多糖与肠道微生物群的相互作用及其对人类健康的影响:综述
Biology (Basel). 2023 Jan 12;12(1):122. doi: 10.3390/biology12010122.
3
The regulatory effect of polysaccharides on the gut microbiota and their effect on human health: A review.多糖对肠道微生物群的调节作用及其对人类健康的影响:综述
Int J Biol Macromol. 2024 Jun;270(Pt 2):132170. doi: 10.1016/j.ijbiomac.2024.132170. Epub 2024 May 9.
4
Recent progress in plant-derived polysaccharides with prebiotic potential for intestinal health by targeting gut microbiota: a review.植物源具有肠道健康益生元潜力的多糖的最新研究进展:综述。
Crit Rev Food Sci Nutr. 2024;64(33):12242-12271. doi: 10.1080/10408398.2023.2248631. Epub 2023 Aug 31.
5
The Influence of Polysaccharides on Lipid Metabolism: Insights from Gut Microbiota.多糖对脂代谢的影响:来自肠道微生物组的新见解。
Mol Nutr Food Res. 2024 Jan;68(1):e2300522. doi: 10.1002/mnfr.202300522. Epub 2023 Nov 7.
6
Research progress of natural plant polysaccharides inhibiting inflammatory signaling pathways and regulating intestinal flora and metabolism to protect inflammatory bowel disease.天然植物多糖通过抑制炎症信号通路和调节肠道菌群及代谢保护炎症性肠病的研究进展。
Int J Biol Macromol. 2023 Dec 31;253(Pt 4):126799. doi: 10.1016/j.ijbiomac.2023.126799. Epub 2023 Sep 12.
7
Dietary glycation compounds - implications for human health.饮食糖化化合物 - 对人类健康的影响。
Crit Rev Toxicol. 2024 Sep;54(8):485-617. doi: 10.1080/10408444.2024.2362985. Epub 2024 Aug 16.
8
The structure-function relationships and interaction between polysaccharides and intestinal microbiota: A review.多糖与肠道微生物群之间的结构-功能关系及相互作用:综述
Int J Biol Macromol. 2025 Feb;291:139063. doi: 10.1016/j.ijbiomac.2024.139063. Epub 2024 Dec 20.
9
Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review.肠道微生物群与代谢性疾病中天然生物活性多糖的相互作用:综述。
Nutrients. 2024 Aug 24;16(17):2838. doi: 10.3390/nu16172838.
10
Pectic polysaccharides: Targeting gut microbiota in obesity and intestinal health.果胶多糖:靶向肥胖和肠道健康中的肠道微生物群。
Carbohydr Polym. 2022 Jul 1;287:119363. doi: 10.1016/j.carbpol.2022.119363. Epub 2022 Mar 18.

引用本文的文献

1
Antibacterial Polysaccharides in Dental Implantology.口腔种植学中的抗菌多糖
Mar Drugs. 2025 Aug 4;23(8):321. doi: 10.3390/md23080321.
2
The Potential Role and Effective Components of Sanyeqing as the Potential Therapeutic Candidates for IBD and CRC.三叶青作为炎症性肠病和结直肠癌潜在治疗候选药物的潜在作用及有效成分
Onco Targets Ther. 2025 Jul 7;18:779-788. doi: 10.2147/OTT.S516341. eCollection 2025.
3
Modulatory Role of Hesperetin-Copper(II) on Gut Microbiota in Type 2 Diabetes Mellitus Mice.橙皮素 - 铜(II)对2型糖尿病小鼠肠道微生物群的调节作用

本文引用的文献

1
Polysaccharides from Sacha Inchi shell reduces renal fibrosis in mice by modulating the TGF-β1/Smad pathway and intestinal microbiota.麻疯树籽壳多糖通过调节 TGF-β1/Smad 通路和肠道微生物群减轻小鼠肾纤维化。
Int J Biol Macromol. 2024 Nov;280(Pt 4):136039. doi: 10.1016/j.ijbiomac.2024.136039. Epub 2024 Sep 25.
2
A review: Polysaccharides targeting mitochondria to improve obesity.综述:靶向线粒体的多糖改善肥胖。
Int J Biol Macromol. 2024 Oct;277(Pt 3):134448. doi: 10.1016/j.ijbiomac.2024.134448. Epub 2024 Aug 3.
3
β-glucan: a potent adjuvant in immunotherapy for digestive tract tumors.
Foods. 2025 Jul 6;14(13):2390. doi: 10.3390/foods14132390.
4
Hawthorn leaf and its extract alleviate high-fat diet-induced obesity and modulate gut microbiome in mice.山楂叶及其提取物可减轻高脂饮食诱导的小鼠肥胖,并调节其肠道微生物群。
Curr Res Food Sci. 2025 Mar 5;10:101025. doi: 10.1016/j.crfs.2025.101025. eCollection 2025.
5
Beneficial Effects of Butyrate on Kidney Disease.丁酸盐对肾脏疾病的有益作用。
Nutrients. 2025 Feb 22;17(5):772. doi: 10.3390/nu17050772.
β-葡聚糖:消化道肿瘤免疫治疗中的有效佐剂。
Front Immunol. 2024 Jul 19;15:1424261. doi: 10.3389/fimmu.2024.1424261. eCollection 2024.
4
Guava polysaccharides attenuate high fat and STZ-induced hyperglycemia by regulating gut microbiota and arachidonic acid metabolism.番石榴多糖通过调节肠道微生物群和花生四烯酸代谢来减轻高脂和 STZ 诱导的高血糖。
Int J Biol Macromol. 2024 Sep;276(Pt 1):133725. doi: 10.1016/j.ijbiomac.2024.133725. Epub 2024 Jul 8.
5
Advances in the treatment of type 2 diabetes mellitus by natural plant polysaccharides through regulation of gut microbiota and metabolism: A review.天然植物多糖通过调节肠道菌群和代谢治疗 2 型糖尿病的研究进展:综述。
Int J Biol Macromol. 2024 Aug;274(Pt 2):133466. doi: 10.1016/j.ijbiomac.2024.133466. Epub 2024 Jun 26.
6
Structural characterization and human gut microbiota fermentation in vitro of a polysaccharide from Fucus vesiculosus.一种来自泡叶藻的多糖的结构特征及其在人体肠道微生物体外发酵的研究。
Int J Biol Macromol. 2024 Aug;275(Pt 1):133369. doi: 10.1016/j.ijbiomac.2024.133369. Epub 2024 Jun 22.
7
Codonopsis pilosula polysaccharides (CPP) intervention alleviates sterigmatocystin (STC)-induced liver injury and gut microbiota dysbiosis.党参多糖(CPP)干预可减轻杂色曲霉素(STC)诱导的肝损伤和肠道微生物群落失调。
Int J Biol Macromol. 2024 Aug;275(Pt 2):133190. doi: 10.1016/j.ijbiomac.2024.133190. Epub 2024 Jun 17.
8
Pleurotus eryngii polysaccharides alleviate aflatoxin B-induced liver inflammation in ducks involving in remodeling gut microbiota and regulating SCFAs transport via the gut-liver axis.杏鲍菇多糖通过调节肠道-肝脏轴重塑肠道微生物群和调控 SCFAs 转运缓解鸭黄曲霉毒素 B 诱导的肝炎症。
Int J Biol Macromol. 2024 Jun;271(Pt 1):132371. doi: 10.1016/j.ijbiomac.2024.132371. Epub 2024 May 13.
9
The regulatory effect of polysaccharides on the gut microbiota and their effect on human health: A review.多糖对肠道微生物群的调节作用及其对人类健康的影响:综述
Int J Biol Macromol. 2024 Jun;270(Pt 2):132170. doi: 10.1016/j.ijbiomac.2024.132170. Epub 2024 May 9.
10
Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway.牛膝多糖通过肠道微生物群衍生的短链脂肪酸诱导的GLP-1/GLP-1R/cAMP/PKA/CREB/INS途径激活来改善2型糖尿病。
Int J Biol Macromol. 2024 Jun;270(Pt 2):132256. doi: 10.1016/j.ijbiomac.2024.132256. Epub 2024 May 9.